# Trade Mark Journal No.2026/027 3 July 2026

## WO0000001922872 (5)

Office of origin: United States of America

Date of International Registration:16 April 2026
Date of designation in the UK: 16 April 2026

The mark consists of three solid, opaque magenta, royal blue, and navy blue circles in a dynamic, triangular arrangement, each emitting a tapering, gradient-shaded trail.

The mark contains the colours magenta, royal blue, navy blue.

The mark contains three solid, opaque magenta, royal blue, and navy blue circles in a dynamic, triangular arrangement, each emitting a tapering, gradient-shaded trail.

International priority date claimed: 27 October 2025 (United States of America) (99464027)

Class 5
  Pharmaceutical preparations for the treatment of cancer and tumors, and autoimmune diseases and disorders; biological preparations for the treatment of cancer; biologics in the nature of pharmaceutical preparations for the treatment of cancer.

Kite Pharma, Inc.

Representative: Cynthia Smuzynska Gilead Sciences, Inc., 333 Lakeside Drive, Foster City CA 94404, UNITED STATES OF AMERICA